Unfortunately, concentrated resveratrol products are poorly soluble and have limited absorption. To overcome these limitations, SourceOne utilizes the VESIsorb® delivery system which dramatically improves the pharmacokinetic parameters (Cmax, Tmax, and AUC) of resveratrol.
The benefits are unmatched:
- Faster onset, independent of food/fat status.
- Fewer servings required to achieved the desired therapeutic effect.
- Superior loading for smaller and easier to consumer capsules.
- Addressing issues related to poor absorption like age, diet, and gender.
Simply put, this formula delivers unmatched blood plasma levels of resveratrol in an elegant softgel capsule.
In a dissolution study, resveratrol with the VESIsorb® delivery system demonstrated 100% dissolution, the ability to dissolve readily in an aqueous environment for absorption, compared to less than 1% for powder.
In a 30-day, randomized double-blind crossover trial, 150 mg resVida® resveratrol supported a variety of cardio metabolic health markers. Resveratrol promoted AMPK activity and SIRT1 and PGC-1α protein levels, biomarkers that positively correlate with metabolic health and mitochondrial function. Resveratrol also promoted healthy blood flow, adipose tissue lipolysis and hepatic lipid content.